Keytruda (pembrolizumab)

pCPA File Number: 20988
Negotiation Status:
Concluded with an LOI
Indication(s):
Classic Hodgkin's Lymphoma
Sponsor/Manufacturer:
Merck Canada Inc.
CADTH Project Number:
pCODR 10109
pCPA Engagement Letter Issued:
Negotiation Process Concluded: